We recently published 10 Stocks Delivering Double-Digit Gains Effortlessly; 4 Hit Highs. Corvus Pharmaceuticals Inc.

Sanofi said its amlitelimab drug confirmed its potential to treat eczema in patients 12 years and older in two late-phase ...

The US Food and Drug Administration (FDA) today announced it has expanded the approval of tralokinumab-ldrm (Adbry) for treating moderate to severe atopic dermatitis (AD) in children 12-17 years old, ...

Sanofi (EPA: SASY) has announced encouraging late-stage clinical trial results for its investigational drug amlitelimab, ...

FILE PHOTO: Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo (Reuters) -Eli Lilly announced on Friday safety ...

A Geelong mum-of-three has searched far and wide for a uniform her eczema-suffering son can wear without triggering painful ...

Corvus Pharma reports encouraging data for its eczema drug soquelitinib, showing strong skin improvement and no serious ...

A clinical review breaks down the latest best practices for managing severe atopic dermatitis (AD) in pregnancy. The review, which appears in Clinical Medicine, was developed by a team of British ...

Jia Patrick told Newsweek that living with TSW has been "a truly harrowing experience" that will take a long time to recover from.

We recently published 10 Big Names Stumbling Hard. Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) was one of the worst performers ...